Ondansetron 4mg/5ml Solution
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. You can take this medication with or without food. If you're using the liquid form, measure your dose carefully using the measuring device that comes with the medication. If one isn't provided, ask your pharmacist for a suitable measuring device.
Storing and Disposing of Your Medication
Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep the medication upright with the cap on. Ensure that all medications are kept in a safe location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, consult your pharmacist for guidance on the best disposal method or inquire about potential drug take-back programs in your area.
Missing a Dose
If you take this medication regularly and miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, follow your doctor's instructions and do not take it more frequently than recommended.
Lifestyle & Tips
- Take this medication exactly as prescribed by your doctor. Do not take more or less than directed.
- Measure the oral solution carefully using the provided measuring device (oral syringe or cup) to ensure you get the correct dose.
- You can take this medication with or without food.
- If you miss a dose, take it as soon as you remember. If it's close to your next dose, skip the missed dose and continue your regular schedule. Do not double doses.
- Stay hydrated, especially if you are experiencing vomiting or diarrhea.
- Report any unusual side effects, especially severe dizziness, fainting, chest pain, or irregular heartbeat, to your doctor immediately.
Available Forms & Alternatives
Available Strengths:
- Ondansetron ODT 8mg Tablets
- Ondansetron ODT 4mg Tablets
- Ondansetron 4mg/5ml Solution
- Ondansetron 2mg/ml Inj, 2ml
- Ondansetron 8mg Tablets
- Ondansetron 4mg Tablets
- Ondansetron 8mg Tablets
- Ondansetron 4mg Tablets
- Ondansetron 4mg/2ml Inj, 2ml
- Ondansetron 4mg Tablets
- Ondansetron 40mg/20ml Inj, 20ml
- Ondansetron 4mg/2ml Pf Syr Inj, 2ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Trouble passing urine
Dizziness
Sudden chest pain or tightness
Abnormal heartbeat, including a fast or irregular heartbeat, or fainting (this medication can cause a prolonged QT interval, which may lead to a potentially life-threatening abnormal heartbeat called torsades de pointes)
Serotonin syndrome, a severe and potentially life-threatening condition, which may be more likely to occur if you are taking certain other medications. Symptoms include:
+ Agitation
+ Change in balance
+ Confusion
+ Hallucinations
+ Fever
+ Fast or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea
+ Upset stomach or vomiting
+ Severe headache
Stomach pain or swelling of the stomach area, especially if you have had surgery in the stomach area or have experienced upset stomach and vomiting after chemotherapy (this medication may mask the signs of a bowel block)
Other Possible Side Effects
Most people do not experience severe side effects, and many have no side effects or only minor ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Headache
Feeling tired or weak
Diarrhea or constipation
Feeling sleepy
Anxiety
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting
- Chest pain or discomfort
- Fast, slow, or irregular heartbeat (palpitations)
- Severe headache
- Blurred vision or temporary vision loss
- Signs of an allergic reaction (e.g., rash, itching, swelling of the face/lips/tongue/throat, severe dizziness, trouble breathing)
- Signs of serotonin syndrome (e.g., agitation, confusion, hallucinations, rapid heart rate, sweating, muscle stiffness or twitching, fever, severe diarrhea)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a prolonged QT interval visible on an electrocardiogram (ECG).
* If you are currently taking apomorphine.
This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, as well as any existing health problems, to your doctor and pharmacist. This will help ensure that it is safe for you to take this medication in conjunction with your other treatments and health conditions.
Remember, do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor to confirm that it is safe to do so.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Severe constipation
- Hypotension (low blood pressure)
- Vasovagal episode with transient AV block
- Transient blindness
- Serotonin syndrome
- QT interval prolongation
- Torsades de Pointes
What to Do:
In case of overdose, seek immediate medical attention. Call your local poison control center (e.g., 1-800-222-1222 in the US) or emergency services. Treatment is supportive and symptomatic. ECG monitoring is recommended due to the risk of QT prolongation.
Drug Interactions
Contraindicated Interactions
- Apomorphine (concurrent use with ondansetron can cause profound hypotension and loss of consciousness)
Major Interactions
- Drugs that prolong the QT interval (e.g., amiodarone, sotalol, quinidine, procainamide, disopyramide, dofetilide, dronedarone, chlorpromazine, thioridazine, pimozide, ziprasidone, haloperidol, methadone, moxifloxacin, erythromycin, pentamidine, cisapride, dolasetron, granisetron, palonosetron) - increased risk of Torsades de Pointes.
- Serotonergic drugs (e.g., SSRIs, SNRIs, MAOIs, tricyclic antidepressants, mirtazapine, fentanyl, tramadol, linezolid, triptans) - increased risk of serotonin syndrome.
Moderate Interactions
- CYP3A4 inducers (e.g., phenytoin, carbamazepine, rifampin) - may decrease ondansetron plasma concentrations, potentially reducing efficacy.
- CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) - may increase ondansetron plasma concentrations, but generally not clinically significant.
Minor Interactions
- Not specifically identified as minor, but general caution with drugs affecting GI motility.
Monitoring
Baseline Monitoring
Rationale: To assess baseline QT interval, especially in patients with pre-existing cardiac conditions, electrolyte abnormalities, or those taking other QT-prolonging medications.
Timing: Before initiation of therapy in at-risk patients.
Rationale: To identify and correct any electrolyte imbalances (hypokalemia, hypomagnesemia) that can increase the risk of QT prolongation.
Timing: Before initiation of therapy in at-risk patients.
Rationale: To assess hepatic function, particularly in patients with known or suspected hepatic impairment, as dose adjustment is required in severe hepatic impairment.
Timing: Before initiation of therapy in patients with suspected hepatic impairment.
Routine Monitoring
Frequency: Daily, especially during initial therapy
Target: Regular bowel movements
Action Threshold: Persistent constipation or diarrhea; consider laxatives for constipation or antidiarrheals for diarrhea.
Frequency: Regularly, especially if co-administered with other serotonergic drugs
Target: Absence of symptoms
Action Threshold: Mental status changes (agitation, hallucinations, coma), autonomic instability (tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (hyperreflexia, incoordination), and/or gastrointestinal symptoms (nausea, vomiting, diarrhea). Discontinue ondansetron and other serotonergic agents immediately.
Frequency: As clinically indicated, especially in patients with risk factors for QT prolongation or on high doses.
Target: <450 ms (men), <470 ms (women)
Action Threshold: Significant QTc prolongation (>500 ms or increase of >60 ms from baseline). Consider dose reduction or discontinuation.
Symptom Monitoring
- Nausea and vomiting (efficacy)
- Headache
- Constipation
- Diarrhea
- Dizziness
- Fatigue
- Rash
- Signs of hypersensitivity reaction (e.g., swelling of face, lips, tongue, throat, difficulty breathing)
- Chest pain, palpitations, irregular heartbeat (potential QT prolongation)
- Changes in mental status, agitation, muscle rigidity, tremors, sweating (signs of serotonin syndrome)
Special Patient Groups
Pregnancy
Ondansetron is generally considered to have a low risk for use during pregnancy, particularly for severe nausea and vomiting of pregnancy (NVP) or hyperemesis gravidarum, when other measures have failed. However, use should be based on a careful risk-benefit assessment. Some studies have suggested a small, increased risk of oral clefts, but overall data are conflicting and do not establish a definitive causal link.
Trimester-Specific Risks:
Lactation
Ondansetron is excreted into human breast milk. The amount transferred to the infant is relatively low. The American Academy of Pediatrics considers it compatible with breastfeeding. Monitor breastfed infants for potential adverse effects such as constipation or diarrhea.
Pediatric Use
Dosing is weight- or body surface area (BSA)-based for children, especially for chemotherapy-induced nausea and vomiting. The half-life is shorter in children compared to adults. Safety and efficacy in infants younger than 6 months have not been established for oral solution. Close monitoring for side effects is important.
Geriatric Use
No specific dose adjustment is required based on age alone. However, elderly patients may be at increased risk for QT prolongation due to age-related physiological changes, co-morbidities, and concomitant medications. Monitor ECG and electrolytes more closely in this population.
Clinical Information
Clinical Pearls
- Ondansetron is highly effective for preventing and treating chemotherapy-induced, radiation-induced, and postoperative nausea and vomiting.
- The oral solution provides flexibility for patients who have difficulty swallowing tablets or require precise dose adjustments.
- Be mindful of the potential for QT prolongation, especially in patients with underlying cardiac conditions, electrolyte imbalances, or those on other QT-prolonging drugs.
- Constipation is a common side effect; advise patients on preventive measures like increased fluid intake and fiber.
- While generally well-tolerated, be vigilant for signs of serotonin syndrome, particularly if co-administered with other serotonergic agents.
- For CINV, administer the first dose before chemotherapy to maximize efficacy.
Alternative Therapies
- NK1 receptor antagonists (e.g., aprepitant, fosaprepitant, netupitant/palonosetron combination) - often used in combination with 5-HT3 antagonists and corticosteroids for highly emetogenic chemotherapy.
- Corticosteroids (e.g., dexamethasone) - commonly used as adjuncts for antiemetic prophylaxis.
- Dopamine receptor antagonists (e.g., prochlorperazine, metoclopramide) - older class of antiemetics, may have more extrapyramidal side effects.
- Antihistamines (e.g., promethazine, diphenhydramine) - for mild nausea, often sedating.
- Cannabinoids (e.g., dronabinol, nabilone) - for refractory CINV.